In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: Level A in vitro-in vivo correlation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 75, Issue 2, 2010, Pages 232-237

  Ochoa, Lourdes ^a   Igartua, Manoli ^a   Hernández, Rosa M ^a   Solinís, Maria Ángeles ^a   Gascón, Alicia R ^a   Pedraz, Jose Luis ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Binder; IVIVC; Melt granulation; Sustained release; Theophylline

Indexed keywords

ETOFYLLINE; GLYCEROL STEARATE; MACROGOL 6000; THEOPHYLLINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG GRANULATION; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOGS; EXCIPIENTS; GLYCERIDES; HYDROPHOBICITY; POLYETHYLENE GLYCOLS; SOLUBILITY; TABLETS; THEOPHYLLINE;

EID: 77952952552     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.02.008     Document Type: Article

References (37)

1. Li V.H.K., Robinson J.R. Fundamentals of controlled release drug delivery. Controlled Drug Delivery: Fundamentals and Applications 1987, 3-11. Marcel Dekker, New York. J.R. Robinson, V.H.L. Lee (Eds.).
2. Bayomi M.A., Al-Suwayeh S.A., El-Helw A.R. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation. Drug Dev. Ind. Pharm. 2001, 27:499-506.
3. Hardy I.J., Windberg-Baarup A., Neri C., Byway P.V., Booth S.W., Fitzpatrick S. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone. Int. J. Pharm. 2007, 337:246-253.
4. Zuleger S., Fassihi R., Lippold B.C. Polymer particle erosion controlling drug release. II. Swelling investigations to clarify the release mechanism. Int. J. Pharm. 2002, 247:23-37.
5. Heller J. Fundamentals of controlled release drug delivery. In Controlled Drug Delivery: Fundamentals and Applications 1987, 140-174. Marcel Dekker, Inc., New York. J.R. Robinson, V.H.L. Lee (Eds.).
6. Ford J.L., Rubinstein M.H., Hogan J.E. Formation of sustained release promethazine hydrochloride tablets using hydroxypropylmethylcellulose matrix. Int. J. Pharm. 1985, 24:327-338.
7. Lee B.J., Riu S.G., Cui S.H. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev. Ind. Pharm. 1999, 25:493-501.
8. Goole J., Vanderbist F., Amighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int. J. Pharm. 2007, 334:35-41.
9. Perissutti B., Rubessa F., Moneghini M., Voinovich D. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Int. J. Pharm. 2003, 256:53-63.
10. Royce A., Suryawanshi J., Shah U., Vishnupad K. Alternative granulation technique: melt granulation. Drug Dev. Ind. Pharm. 1996, 22:917-924.
11. Bjorn I.N., Jansson A., Karlsson M., Folestad S., Rasmuson A. Empirical to mechanistic modelling in high shear granulation. Chem. Eng. Sci. 2005, 60:3795-3803.
12. Hamdani J., Moes A.J., Amighi K. Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int. J. Pharm. 2002, 245:167-177.
13. Yang D., Kulkarni R., Behme R.J., Kotiyan P.N. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin. Int. J. Pharm. 2007, 329:72-80.
14. Goole J., Deleuze P., Vanderbist F., Amighi K. New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer. Eur. J. Pharm. Biopharm. 2008, 68:310-318.
15. Hauss D.J. Oral lipid-based formulations. Adv. Drug Deliv. Rev. 2007, 59:667-676.
16. Shimpi S., Chauhan B., Mahadik K.R., Paradkar A. Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation. AAPS PharmSciTech 2004, 5(3).
17. Sirisuth N., Augsburger L.L., Eddington N.D. Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation. Biopharm. Drug Dispos. 2002, 23:1-8.
18. Hussein Z., Friedman M. Release and absorption characteristics of novel theophylline sustained release formulations: in vitro-in vivo correlation. Pharm. Res. 1990, 7:1167-1171.
19. Varshosaz J., Ghafghazi T., Raisi A., Falamarzian M. Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies. Eur. J. Pharm. Biopharm. 2000, 50:301-306.
20. Shan-Yang L., Yuh-Horng K., Hsiao-Ning C. Preliminary evaluation of the correlation between in vitro release and in vivo bioavailability of two aminophylline slow-release tablets. J. Pharm. Sci. 1990, 79:326-330.
21. Ochoa L., Igartua M., Hernandez R.M., Gascon A.R., Pedraz J.L. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. J. Pharm. Pharm. Sci. 2005, 8:132-140.
22. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 1985, 60:110-111.
23. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35.
24. Winnolin 4.1, Pharshigt Corporation, Mountain View, California, 2003.
25. Food and Drug Administration: Guidance for Industry, Bioanalytical Methods Validation for Human Studies, US Department of Health and Human Services/Food and Drug Administration/Center for Drug Evaluation and Research, Rockville, MD, 1998.
26. ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Q2/R1 Validation of Analytical Procedures. Text and Methodology, 1995.
27. Shapiro S.S., Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika 1965, 52:591-611.
28. H. Levene, Robust tests for equality of variances, in: I. Olkin, S.G. Ghurye, W. Hoeffding, W.G. Madow, H.B. Mann (Eds.), Contribution to Probability and Statistics, 1960, pp. 278-292.
29. Munday D.L., Fassihi A.R. In vitro-in vivo correlation studies on a novel controlled release theophylline delivery system and on Theo-Dur tablets. Int. J. Pharm. 1995, 118:251-255.
30. Kosmidis K., Argyrakis P., Macheras P. A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function. Pharm. Res. 2003, 20:988-995.
31. Papadopoulou V., Kosmidis K., Vlachou M., Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int. J. Pharm. 2006, 309:44-50.
32. Siepmann J., Streubel A., Peppas N.A. Understanding and predicting drug delivery from hydrophilic matrix tablets using the " sequential layer" model. Pharm. Res. 2002, 19:306-314.
33. Abdelbary G.A., Tadros M.I. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur. J. Pharm. Biopharm. 2008, 69:1019-1028.
34. Passerini N., Albertini B., Perissutti B., Rodriguez L. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel. Int. J. Pharm. 2006, 318:92-102.
35. Hernández R.M., Gascón A.R., Calvo M.B., Caramella C., Conte U., Domínguez-Gil A., Pedraz J.L. Correlation of 'in vitro' release and 'in vivo' absorption characteristics of four salbutamol sulphate formulations. Int. J. Pharm. 1996, 139:45-52.
36. Qiu Y., Cheskin H.S., Engh K.R., Poska R.P. Once-a-day controlled-release dosage form of divalproex sodium I: formulation design and in vitro/in vivo investigations. J. Pharm. Sci. 2003, 92:1166-1173.
37. Food and Drug Administration: Guidance for Industry. Extended Release Solid Oral Dosage Forms. Development, Evaluation and Application of In Vitro/In Vivo Correlations, US Department of Health and Human Services/Food and Drug Administration/Center for Drug Evaluation and Research, Rockville, MD, 1997.